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Abstract 
Female hooded-Lister rats received either sub-chronic phencyclidine (PCP) (2 mg/kg, 
n=20) or vehicle (1 ml/kg, n=20) i.p. twice daily for seven days, followed by a seven-
day washout period.  Rats were challenged with acute PCP or vehicle and tested for 
locomotor activity to ensure hyperactivity was observed in the sub-chronic PCP 
treated rats.  Rats were then tested on the elevated plus maze and in an open field for 
10 minutes.  Sub-chronic PCP did not significantly affect behaviour on the elevated 
plus maze or in the open field.  In conclusion, sub-chronic PCP does not induce 
anxiety-like behaviour.  
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Introduction 
The non-competitive NMDA receptor antagonist, phencyclidine (PCP), has been 
shown to produce enduring cognitive deficits similar to those observed in 
schizophrenia (Javitt and Zukin, 1991) particularly when administered sub-chronically 
rather then acutely (Jentsch and Roth, 1999).  PCP produces inactivation of inhibitory 
control by decreasing GABA release (Yonezawa et al., 1998).  This disinhibition of 
excitatory neurotransmission is referred to as NMDA receptor hypofunction (Olney et 
al., 1999).  In our laboratory sub-chronic PCP administration to adult female rats has 
produced cognitive deficits in attentional set-shifting (McLean et al., 2008), reversal 
learning (Abdul-Monim et al., 2006) and novel object recognition (Grayson et al., 
2007).  Furthermore, we have found females to be better at certain cognitive tasks 
compared with males, for example novel object recognition, and that this performance 
is not significantly affected by stage of the oestrous cycle (Sutcliffe et al., 2007).  This 
regimen has also produced social interaction deficits in our laboratory in female rats 
(Snigdha et al., 2008).  In addition, it has been demonstrated that sub-chronic PCP 
reduces the density of parvalbumin-immunoreactive neurons in the hippocampus 
(Abdul-Monim et al., 2007), and brain-derived neurotrophic factor (BDNF) levels in 
cortical regions (Snigdha et al., 2007) in female rats.  Similar cognitive impairments 
(Rodefer et al., 2005), neurochemical deficits (Cochran et al., 2003) as well as 
metabolic hypofunction (Reynolds et al., 2005) have previously been reported in male 
rats.  
The aim of this study was to investigate whether sub-chronic PCP 
administration to adult female rats produces anxiety-like behaviour in two tests, 
namely the elevated plus maze (Pellow et al., 1985) and open field (Walsh and 
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Cummins, 1976) tests which could confound results in novel object recognition and 
other cognitive tests.  
 
Materials and methods 
Forty adult female hooded-Lister rats weighing 200-250 g were housed in groups of 
five in standard laboratory conditions with free access to food and water.  Light 
intensity in the holding and behavioural testing rooms was 400-500 lx. All 
experimental procedures were carried out in accordance with the Animals (Scientific 
Procedures) Act, UK (1986) and were approved by the University of Bradford ethical 
review process.  At adulthood 20 rats received sub-chronic PCP (2 mg/kg) and 20 rats 
received vehicle (0.9% saline, 1 ml/kg) i.p. twice daily for seven days, followed by a 
seven-day washout period. PCP HCl (Sigma, UK) was dissolved in 0.9% saline and 
injected via the intraperitoneal (i.p.) route in a volume of 1 ml/kg. 
The locomotor activity (LMA) response to a novel environment was monitored 
using automated photocell cages.  The movement of each animal was monitored in a 
Plexiglas chamber (16 x 26 x 19 cm) covered with a compatible Plexiglas lid using 
AM1052 Activity Monitor (Linton Instrumentation).  Rats were habituated to the 
cages for 2 hours on the day prior testing.  On the test day, rats were either given an 
acute dose of PCP (2 mg/kg, i.p.) or vehicle (0.9% saline, i.p.) and were placed in the 
LMA boxes immediately after dosing.  The acute dose of PCP was chosen based on a 
previous study showing that 2 mg/kg can produce cognitive deficits without affecting 
locomotor activity (Grayson, unpublished findings).  Therefore, there were 4 test 
groups (all n=10) sub-chronic vehicle-vehicle, sub-chronic vehicle-PCP, sub-chronic 
PCP-vehicle, sub-chronic PCP-PCP.  Counts were recorded by AmLogger software 
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(supplied by GSK, Harlow, UK) by means of photo beam interruptions within the 
chamber.  Activity was monitored every 5min over a 120-min period.  Rats were 
challenged to ensure that the sub-chronic PCP regimen was effective.  The rats that 
did not receive the PCP challenge (veh-veh (n=10) and PCP-veh (n=10)) then went on 
to be tested in the elevated plus maze and open field paradigms.   
 The elevated plus maze (constructed in house) consisted of four arms elevated 
50 cm above the floor.  Each arm (12 cm wide, 46 cm long) was joined to the others 
by a central square (12 cm×12 cm) in a cross-like disposition.  A wall (12 cm in 
height) enclosed two opposite arms, while the other two arms were open.  Placing the 
rat on the platform facing an open arm started the test.  The arms of the maze were 
cleaned between the tests.  The experimenter monitored the movements of the rats via 
a video camera mounted above the maze, and recordings were scored using Hindsight 
version 1.  During the 10 min test session, the number of entries into the open or 
closed-arms and the time spent in the open or closed-arms were recorded. The rats 
were considered to have entered an arm when all four limbs were located in an arm of 
the maze. 
 The open field arena (constructed in house) consisted of an open box (52 cm 
wide by 40 cm high by 52 cm long) with black Perspex sides, a white Perspex base 
and black grid lines dividing the arena into 9 equally sized squares.  No additional 
illumination was placed on the box and the box was placed in the experimental room 
in such a position where no shadows fell.  Placing the rat in the centre square started 
the test.  The arena was cleaned in between tests.  The experiment was recorded and 
scored as described previously for the elevated plus maze.  During the 10 min test 
session, the number of entries into the centre square and the time spent in the centre 
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square were recorded.  The rats were considered to have entered a square when all 
four limbs were located in that square of the arena. 
Area under the curve was calculated for the LMA data using the trapezoid 
rule, and analysed using post-hoc Bonferroni’s multiple comparison test.  Independent 
Student’s t-tests were carried out on the elevated plus maze and open field data 
between the vehicle and PCP treated groups. 
 
Results 
Bonferroni’s multiple comparison test on the area under the curves (figure 1A) and 
the total LMA counts (figure 1B) showed that the PCP-PCP group was significantly 
more active compared to veh-veh (P<0.05), veh-PCP (P<0.01) and PCP-veh (P<0.01) 
groups.  There were no significant differences between the other groups.  Rats which 
had received an acute dose of vehicle were then tested in the behavioural paradigms 
(vehicle and PCP n=10).  Rats were excluded from the elevated plus maze study if 
they did not remain on the maze for the full test session, therefore groups for the 
elevated plus maze experiment were n=8.  Behaviour in the open field and on the 
elevated plus maze was unaffected by sub-chronic PCP with no significant differences 
observed between groups in time spent in the open/closed arms and number of entries 
into the arms, or time spent and entries into the centre square of the open field (table 
1).  As the number of open arm entries appears low in the vehicle group, this 
parameter was also measured after 5 min, revealing that the number of open arm 
entries for vehicles was 4.4 ± 0.5 compared to 4.5 ± 0.4 in the PCP group; there was 
no significant difference between these groups (P=0.844). 
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Discussion 
This study examined whether sub-chronic PCP would induce anxiety-like behaviour 
in the adult rat.  The main findings were that sub-chronic PCP had no effect on 
behaviour in the open field or elevated plus maze.  Following an acute challenge with 
PCP, we observed an increase in locomotor activity in the sub-chronic PCP treated 
rats, with no effect in vehicle treated animals. Previous studies in male rats, using 
similar treatment regimes at comparable doses have reported similar findings 
(Kalinichev et al., 2008). This sensitisation in the sub-chronic PCP treated animals 
may be related to the disruption of GABAergic interneurons in the medial prefrontal 
cortex (Abekawa et al., 2007).  Taken together these results indicate that the sub-
chronic PCP regimen was successful in producing behavioural changes in these 
animals thus validating the treatment  prior to testing in the anxiety paradigms. 
The elevated plus-maze (Pellow et al., 1985) involves placing a naive rat in 
the centre of an elevated plus-maze with two open and two enclosed arms, and 
allowing it to freely explore (Rodgers and Cole, 1993).  It has been suggested that the 
reluctance of rats to explore the open arms of the maze is caused by fear of open 
spaces, rather than the novelty of the maze or its height (Pellow et al., 1985).  The 
open field test is also a frequently used test of anxiety (Gray, 1979).  Both tests have 
been pharmacologically validated with anxiolytic compounds increasing, and 
conversely anxiogenic compounds decreasing the percentage of time spent in the open 
areas (Pellow et al., 1985; Gentsch et al., 1987; Cole et al., 1995).   
In the present study there were no significant differences between vehicle and 
PCP-treated rats in time spent in each arm or number of entries on the elevated plus 
maze.  There were also no differences in open field behaviour with rats spending a 
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similar duration in the centre square and making a similar number of entries into the 
centre.  These data suggest that sub-chronic PCP does not have an anxiogenic effect 
as assessed by the elevated plus maze or open field test.  Our findings are supported 
by studies using a perinatal (du Bois et al., 2008) and sub-chronic pubertal (Schwabe 
et al., 2006) regimen of PCP dosing which showed no difference in elevated plus 
maze behaviour in adult female and male rats respectively, suggesting that these PCP 
regimes do not produce anxiety-like behaviour.  However, these data are in 
disagreement with a recent study by Audet and co-workers.  They found that sub-
chronic PCP followed by a week washout period resulted in male rats spending less 
time in the lit area of a lit/dark apparatus (Audet et al., 2007).  However, it should be 
noted that they used a different strain and sex of rat and a higher dosing regimen of 5 
mg/kg twice daily for 7 days, compared to our regimen of 2 mg/kg twice daily for the 
same duration.  It is important to note that results vary between laboratories and 
differences are observed between sexes (see Toufexis et al., 2006) and strains (Hall et 
al., 2000; Rex et al., 2004). 
To our knowledge this is the first study into the effects on anxiety of sub-
chronic PCP in female adult hooded-Lister rats.  In conclusion, our sub-chronic PCP 
regimen does not induce anxiety-like behaviour in the open field and elevated plus 
maze tests.  
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Figure 1 
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Table 1  
Behaviour of vehicle and PCP-treated rats on the elevated plus maze and open field 
tests. 
Behaviour Vehicle PCP P value 
    
Elevated plus maze    
    Open arm duration (s) 109.8 ± 11.3 94.2 ± 10.0 0.31 
    Closed arm duration (s) 377.5 ± 18.0 368.9 ± 14.3 0.71 
    Centre duration (s) 112.7 ± 22.2 131.0 ± 7.9 0.45 
    Open arm entries 6.8 ± 0.7 6.6 ± 0.5 0.89 
    Closed arm entries 12.9 ± 0.7 15.5 ± 1.1 0.07 
    Centre entries 19.8 ± 1.3 22.3 ± 1.3 0.20 
    Open arm latency (s) 28.8 ± 6.8 17.4 ± 7.0 0.26 
    
Open field test    
    Centre square duration (s) 25.2 ± 5.9 27.1 ± 4.9 0.80 
    Centre square entries 9.1 ± 1.5 11.1 ± 1.8 0.32 
    Line crossings 111.4 ± 5.9 111.1 ± 8.1 0.98 
 
 
 
Legends 
Figure 1: Locomotor activity in vehicle or sub-chronic PCP-treated rats (2 mg/kg 
twice daily for seven days) following acute challenge with PCP (2 mg/kg) measured 
(A) over a 2-hour period at 5-min intervals and (B) as total LMA count after 2-hours 
(n=10).  Post-hoc Bonferroni multiple comparison test on the area under the curves 
and total LMA showed that the PCP-PCP group was significantly more active 
compared to veh-veh (*P<0.05), veh-PCP (**P<0.01) and PCP-veh (**P<0.01) 
groups.  
 
Table 1:  Behaviour of vehicle and sub-chronic PCP-treated rats on the elevated plus 
maze (n=8) and open field tests (n=10).  Data are means ± S.E.M.  P values were 
obtained from Independent Student’s t-test comparing PCP to vehicle-treated group. 
